Professor and Co-Director University of Minnesota, Department of Pediatrics, Center for Pediatric Obesity Medicine Minneapolis, MN, United States
Disclosure(s):
Claudia Fox, MD MPH: Eli Lilly & Company: Contracted Research (Principal Investigators must provide information, even if received by the institution) (); Novo Nordisk: Contracted Research (Principal Investigators must provide information, even if received by the institution) ()
The rapid evolution of obesity and diabetes therapies demands a renewed focus on equitable, person-centered care. This session will highlight strategies to individualize obesity treatment, incorporating patient preferences, psychosocial context, and long-term support. Speakers will explore global and community perspectives on improving access and reducing disparities in obesity care and address best practices for diabetes management in underserved populations. Together, these presentations will emphasize inclusive approaches that bridge clinical innovation with real-world delivery, ensuring that emerging therapies benefit all patients equitably.
Learning Objectives:
Define the key principles of person-centered care in obesity and diabetes management and how to apply them in clinical practice.
Discuss global and community-level strategies to improve equity and access to effective obesity treatments.
Identify barriers and evidence-based interventions to enhance diabetes care among underserved and marginalized populations.
